Antibiotic Developments Insights
The panel combatting the rise of antibiotic resistance in UTIs
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process. Read more
11 Aug 2022
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research. Read more
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance. Read more
29 Nov 2021
AMR in Orthopedics – Benefits of topical treatment and latest advances
Michael Harris, chief executive officer of Biocomposites explores the threat of antibiotic resistance and how antibiotics are being used within the orthopaedics industry. Read more
7 Oct 2021
Improving our approach to fighting AMR
Oliver Schacht, CEO of precision medicine and genomics analysis company OpGen explores what we need to do to improve our fight against antimicrobial resistance (AMR). Read more
11 Aug 2021
The state of bioinformatics in the fight against AMR
Oliver Schacht, CEO of OpGen, Inc., examines the potential of bioinformatics in helping to fight antimicrobial resistance. Read more
27 Jan 2021
Accelerate Diagnostics announces CE marking of its antimicrobial kit
Accelerate Diagnostics, an in-vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis, announces CE marking of its new Accelerate Arc Module and BC kit. Read more
8 Aug 2022
Quidel Corp provides rapid clinical detection of C. difficile infection
The Sofia 2 C. difficile FIA (Fluorescent Immunoassay), from healthcare manufacturer Quidel Corporation, provides accurate detection of C. difficile in 15 minutes – half the time of comparator assays – allowing rapid treatment decisions. Read more
1 Jul 2022
Novasep and Paratek increase API manufacture for antibiotic
Technology supplier Novasep and Paratek Pharmaceuticals have signed an agreement to increase the commercial production of an active pharmaceutical ingredient (API) for an antibiotic. Read more
21 Feb 2022
Determine the right dust collection equipment for tablet press applications
Download this whitepaper and read through Camfil's 10 tips on the most important factors to consider when determining reliable dust collection solutions for tablet press applications. Read more
13 Oct 2022
The future of patient experience: how connected drug delivery will promote inclusivity and adherence
Michael Earl, director, pharmaceutical services at Owen Mumford, examines the benefits that patients are set to receive as the connected drug delivery devices market grows. Read more
6 Feb 2023
Best served cold: Trends and challenges in the cold chain industry
Dr. Jan Ehlers, chief executive officer at Secop GmbH, shares the trends and challenges in the cold chain industry and the rising demand for vaccine transport solutions. Read more
3 Feb 2023
Andrii Yalanskyi Shutterstock
Government support withdrawal sparks rethink on pharma’s energy strategy
Matt Watson, European Manufacturing Sector expert at Aggreko Europe, is highlighting the importance of looking into other technologies to help maintain power baseloads at a challenging time for the industry. Read more
2 Feb 2023
![Saint-Beauzire_CGAM[4][24] copy.png](https://pharmaceuticalmanufacturer.media/downloads/9558/download/Saint-Beauzire_CGAM%5B4%5D%5B24%5D%20copy.png?cb=f9da762fe7f721f17a3c00fa8a829a6e&w=640 "Saint-Beauzire_CGAM[4][24] copy.png")
CARBOGEN AMCIS SAS © Gilles Framinet
Q&A: CARBOGEN AMCIS dedicates new site to sterile liquid drug manufacturing
As CARBOGEN AMCIS opens its doors to a new sterile liquid drug product manufacturing facility in France, EPM caught up with Pascal Villemagne, CEO of CARBOGEN AMCIS, to discuss what this will mean for CARBOGEN's capabilities in freeze-dried products. Read more
2 Feb 2023
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Shutterstock
Next-generation ADCs: better oncology treatments through innovation
Penelope Drake, Ph.D., head of R&D, Bioconjugates, Catalent, highlights the potential of anti-body-drug conjugates in paving a way to innovation in oncology treatments. Read more
31 Jan 2023
Optimising single-use cleanrooms through associate training
Timothy Korwan, director, new product introductions, Avantor, describes how using a dedicated training room can ensure the reliability and quality of single-use (SU) systems. Read more
30 Jan 2023
![Saint-Beauzire_CGAM[4][24] copy.png](https://pharmaceuticalmanufacturer.media/downloads/9558/download/Saint-Beauzire_CGAM%5B4%5D%5B24%5D%20copy.png?cb=f9da762fe7f721f17a3c00fa8a829a6e&w={width}&h={height} "Saint-Beauzire_CGAM[4][24] copy.png")
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
Determine the right dust collection equipment for tablet press applications
Download this whitepaper and read through Camfil's 10 tips on the most important factors to consider when determining reliable dust collection solutions for tablet press applications. Read more
13 Oct 2022
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
Cole-Parmer
Since 1955, Cole-Parmer has been a leading global supplier of laboratory, process, and fluid handling products, instrumentation, equipment, and supplies. Read more
